Trial Profile
A Single-Center, Retrospective Study Investigating the Safety and Efficacy of Conversion from Tacrolimus to Belatacept after Kidney Transplant (KT) in Terms of Improvement in Renal Function
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jul 2018
Price :
$35
*
At a glance
- Drugs Belatacept (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 13 Jul 2018 New trial record
- 06 Jun 2018 Results presented at the 2018 American Transplant Congress.